294.28
price up icon7.13%   19.58
after-market Handel nachbörslich: 294.28
loading

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

pulisher
Aug 01, 2025

United Therapeutics Announces $1B Accelerated Share Repurchase Program. - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics’ PAH Study Update: Implications for Investors - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics Advances in Pulmonary Fibrosis Treatment with Phase 3 Study - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics (UTHR) Launches $1B Stock Buyback Program - GuruFocus

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics Launches $1 Bln Stock Buyback - Nasdaq

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics stock jumps on $1 billion share repurchase plan - Investing.com

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program - Stock Titan

Aug 01, 2025
pulisher
Aug 01, 2025

Pulmonary Arterial Hypertension Drug Market to See Booming - openPR.com

Aug 01, 2025
pulisher
Aug 01, 2025

What is the dividend policy of United Therapeutics Corporation stockFree Stock Alerts For Every Investor - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

United Therapeutics Reports Record Q2 2025 Financial Results - The Globe and Mail

Aug 01, 2025
pulisher
Jul 31, 2025

BTIG Lowers Liquidia (LQDA) PT to $40, Potential for Yutrepia Launch Remains a Focus - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

United Therapeutics Reports Record Revenue and Growth - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

H.C. Wainwright lowers United Therapeutics stock price target on Tyvaso competition concerns - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

United Therapeutics Corp (UTHR) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

United Therapeutics: Q2 Earnings Snapshot - Greenwich Time

Jul 31, 2025
pulisher
Jul 31, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight - GuruFocus

Jul 31, 2025
pulisher
Jul 30, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for IPF Treatment - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Stock Slides On Q2 Earnings: The Details - 富途牛牛

Jul 30, 2025
pulisher
Jul 30, 2025

Earnings call transcript: United Therapeutics Q2 2025 misses EPS, stock drops - Investing.com

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics - Nasdaq

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Q2 2025 slides: Revenue up 12% as Tyvaso drives growth - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Q2 2025 slides: Revenue up 12% as Tyvaso drives growth By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Logs Growth And Launches Big Buyback - Finimize

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics misses Q2 earnings expectations By Investing.com - Investing.com Canada

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics misses Q2 earnings expectations - Investing.com

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics earnings missed by $0.94, revenue fell short of estimates - Investing.com

Jul 30, 2025
pulisher
Jul 30, 2025

United Therapeutics Delivers Triple Win: Record $799M Revenue, $1B Buyback, and Major Pipeline Progress - Stock Titan

Jul 30, 2025
pulisher
Jul 29, 2025

United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial - MSN

Jul 29, 2025
pulisher
Jul 29, 2025

United Therapeutics’ Promising IPF Treatment Study: A Market Game-Changer? - The Globe and Mail

Jul 29, 2025
pulisher
Jul 29, 2025

Preview: United Therapeutics's Earnings - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

Bleecker Street Research short United Therapeutics, long Liquidia - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 12:41:34 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

United Therapeutics Earnings Announcement and Market OutlookNews and Statistics - IndexBox

Jul 29, 2025
pulisher
Jul 29, 2025

Is There Enough Volume to Lift United Therapeutics CorporationTriple Return Setup With Risk Control Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) - MSN

Jul 29, 2025
pulisher
Jul 29, 2025

Why United Therapeutics Corporation stock attracts strong analyst attentionWeekly Top Gainers Forecast Watchlist Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What institutions are buying United Therapeutics Corporation stock nowEarnings Play Trade Plan With Alerts Shared - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What To Expect From United Therapeutics’s (UTHR) Q2 Earnings - Yahoo.co

Jul 28, 2025
pulisher
Jul 28, 2025

ROSEN, A LEADING LAW FIRM, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate United Therapeutics Corporation as a “Buy”Entry Signal Forecasts With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for Pulmonary Fibrosis - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is United Therapeutics Corporation stock compared to the marketStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about United Therapeutics CorporationRapid-fire capital growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Leerink Partners Remains a Buy on United Therapeutics Corporation (UTHR) With a $408 PT - Insider Monkey

Jul 28, 2025
pulisher
Jul 27, 2025

When is United Therapeutics Corporation stock expected to show significant growthHigh-performance stocks for savvy investors - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is United Therapeutics Corporation stock overvalued or undervaluedHigh-yield portfolio picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes United Therapeutics Corporation stock price move sharplyGet expert analysis on top stock picks - jammulinksnews.com

Jul 27, 2025
$128.91
price up icon 0.53%
drug_manufacturers_specialty_generic RDY
$13.94
price down icon 1.97%
$8.81
price up icon 0.80%
$15.38
price down icon 0.45%
$13.79
price up icon 0.80%
Kapitalisierung:     |  Volumen (24h):